US Stock MarketDetailed Quotes

SER Serina Therapeutics

Watchlist
  • 5.937
  • +0.657+12.44%
Trading Dec 27 11:33 ET
55.76MMarket Cap-98.95P/E (TTM)

Serina Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(FY)Dec 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-189.26%-2.96M
-826.97%-8.01M
-122.43%-1.58M
-1.02M
-864K
-709K
7.78%-2.08M
-2.25M
Net income from continuing operations
-21.06%1.38M
-149.63%-401K
-669.18%-9.44M
--1.75M
--808K
--1.66M
-112.07%-2.68M
---1.26M
Operating gains losses
-1,018.96%-6.67M
----
----
---596K
---291K
---172K
159.80%134.79K
---225.38K
Depreciation and amortization
3.70%56K
235.29%57K
92.31%25K
--54K
--17K
--13K
83.63%61.27K
--33.37K
Other non cash items
-46.87%229K
759.09%378K
45.65%67K
--431K
--44K
--46K
221.31%148.26K
---122.21K
Change In working capital
1,913.46%943K
-4,657.14%-4.79M
151.08%698K
---52K
--105K
--278K
98.42%-11.94K
---754.79K
-Change in receivables
--36K
----
----
--0
----
----
-99.91%1.11K
--1.27M
-Change in prepaid assets
24,400.00%245K
---2.64M
-5,800.00%-57K
--1K
--0
--1K
430.63%1.51K
--284
-Change in payables and accrued expense
12,116.67%721K
-1,543.84%-2.11M
151.40%807K
---6K
--146K
--321K
98.98%-3.89K
---382.19K
-Change in other current liabilities
-25.53%-59K
-34.15%-55K
-18.18%-52K
---47K
---41K
---44K
-309.64%-164.16K
---40.08K
-Change in other working capital
----
----
----
----
----
----
109.55%153.5K
---1.61M
Cash from discontinued investing activities
Operating cash flow
-189.26%-2.96M
-826.97%-8.01M
-122.43%-1.58M
---1.02M
---864K
---709K
7.78%-2.08M
---2.25M
Investing cash flow
Cash flow from continuing investing activities
97.48%-3K
0
-14K
-119K
-315K
0
19.14%980.94K
823.32K
Net PPE purchase and sale
97.48%-3K
--0
---14K
---119K
---315K
--0
91.07%-9.68K
---108.43K
Net investment purchase and sale
----
----
----
----
----
----
6.32%990.62K
--931.76K
Cash from discontinued investing activities
Investing cash flow
97.48%-3K
--0
---14K
---119K
---315K
--0
19.14%980.94K
--823.32K
Financing cash flow
Cash flow from continuing financing activities
4,200.00%86K
48,890.91%5.37M
-72.96%2.73M
2K
-11K
10.09M
21.80%1.31M
1.08M
Net issuance payments of debt
--0
3,258.33%379K
-76.34%2.39M
---12K
---12K
--10.09M
10,231.31%1.31M
---12.91K
Net common stock issuance
----
----
----
----
----
----
--4.42K
--0
Net preferred stock issuance
----
----
----
----
----
----
--0
--90.15K
Proceeds from stock option exercised by employees
514.29%86K
498,700.00%4.99M
--4K
--14K
--1K
--0
----
----
Net other financing activities
--0
--0
--337K
----
----
----
----
--1M
Cash from discontinued financing activities
Financing cash flow
4,200.00%86K
48,890.91%5.37M
-72.96%2.73M
--2K
---11K
--10.09M
21.80%1.31M
--1.08M
Net cash flow
Beginning cash position
-29.90%6.11M
-11.66%8.76M
1,332.14%7.62M
--8.72M
--9.91M
--532K
-52.66%314.85K
--665.06K
Current changes in cash
-152.32%-2.88M
-122.02%-2.64M
-87.88%1.14M
---1.14M
---1.19M
--9.38M
162.07%217.38K
---350.21K
End cash Position
-57.33%3.24M
-29.90%6.11M
-11.66%8.76M
--7.58M
--8.72M
--9.91M
69.04%532.23K
--314.85K
Free cash flow
-159.41%-2.97M
-579.30%-8.01M
-124.40%-1.59M
---1.14M
---1.18M
---709K
11.61%-2.09M
---2.36M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(FY)Dec 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -189.26%-2.96M-826.97%-8.01M-122.43%-1.58M-1.02M-864K-709K7.78%-2.08M-2.25M
Net income from continuing operations -21.06%1.38M-149.63%-401K-669.18%-9.44M--1.75M--808K--1.66M-112.07%-2.68M---1.26M
Operating gains losses -1,018.96%-6.67M-----------596K---291K---172K159.80%134.79K---225.38K
Depreciation and amortization 3.70%56K235.29%57K92.31%25K--54K--17K--13K83.63%61.27K--33.37K
Other non cash items -46.87%229K759.09%378K45.65%67K--431K--44K--46K221.31%148.26K---122.21K
Change In working capital 1,913.46%943K-4,657.14%-4.79M151.08%698K---52K--105K--278K98.42%-11.94K---754.79K
-Change in receivables --36K----------0---------99.91%1.11K--1.27M
-Change in prepaid assets 24,400.00%245K---2.64M-5,800.00%-57K--1K--0--1K430.63%1.51K--284
-Change in payables and accrued expense 12,116.67%721K-1,543.84%-2.11M151.40%807K---6K--146K--321K98.98%-3.89K---382.19K
-Change in other current liabilities -25.53%-59K-34.15%-55K-18.18%-52K---47K---41K---44K-309.64%-164.16K---40.08K
-Change in other working capital ------------------------109.55%153.5K---1.61M
Cash from discontinued investing activities
Operating cash flow -189.26%-2.96M-826.97%-8.01M-122.43%-1.58M---1.02M---864K---709K7.78%-2.08M---2.25M
Investing cash flow
Cash flow from continuing investing activities 97.48%-3K0-14K-119K-315K019.14%980.94K823.32K
Net PPE purchase and sale 97.48%-3K--0---14K---119K---315K--091.07%-9.68K---108.43K
Net investment purchase and sale ------------------------6.32%990.62K--931.76K
Cash from discontinued investing activities
Investing cash flow 97.48%-3K--0---14K---119K---315K--019.14%980.94K--823.32K
Financing cash flow
Cash flow from continuing financing activities 4,200.00%86K48,890.91%5.37M-72.96%2.73M2K-11K10.09M21.80%1.31M1.08M
Net issuance payments of debt --03,258.33%379K-76.34%2.39M---12K---12K--10.09M10,231.31%1.31M---12.91K
Net common stock issuance --------------------------4.42K--0
Net preferred stock issuance --------------------------0--90.15K
Proceeds from stock option exercised by employees 514.29%86K498,700.00%4.99M--4K--14K--1K--0--------
Net other financing activities --0--0--337K------------------1M
Cash from discontinued financing activities
Financing cash flow 4,200.00%86K48,890.91%5.37M-72.96%2.73M--2K---11K--10.09M21.80%1.31M--1.08M
Net cash flow
Beginning cash position -29.90%6.11M-11.66%8.76M1,332.14%7.62M--8.72M--9.91M--532K-52.66%314.85K--665.06K
Current changes in cash -152.32%-2.88M-122.02%-2.64M-87.88%1.14M---1.14M---1.19M--9.38M162.07%217.38K---350.21K
End cash Position -57.33%3.24M-29.90%6.11M-11.66%8.76M--7.58M--8.72M--9.91M69.04%532.23K--314.85K
Free cash flow -159.41%-2.97M-579.30%-8.01M-124.40%-1.59M---1.14M---1.18M---709K11.61%-2.09M---2.36M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSD
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.